DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck.

BACKGROUND AND PURPOSE:It is important to identify patients with head and neck squamous cell carcinoma (SCC) who fail to respond to chemoradiotherapy so that they can undergo post-treatment salvage surgery while the disease is still operable. This study aimed to determine the diagnostic performance...

Full description

Bibliographic Details
Main Authors: Ann D King, Steven Kwok Keung Chow, Kwok-Hung Yu, Frankie Kwok Fai Mo, David K W Yeung, Jing Yuan, Benjamin King Hong Law, Kunwar S Bhatia, Alexander C Vlantis, Anil T Ahuja
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4684338?pdf=render
_version_ 1819159171872849920
author Ann D King
Steven Kwok Keung Chow
Kwok-Hung Yu
Frankie Kwok Fai Mo
David K W Yeung
Jing Yuan
Benjamin King Hong Law
Kunwar S Bhatia
Alexander C Vlantis
Anil T Ahuja
author_facet Ann D King
Steven Kwok Keung Chow
Kwok-Hung Yu
Frankie Kwok Fai Mo
David K W Yeung
Jing Yuan
Benjamin King Hong Law
Kunwar S Bhatia
Alexander C Vlantis
Anil T Ahuja
author_sort Ann D King
collection DOAJ
description BACKGROUND AND PURPOSE:It is important to identify patients with head and neck squamous cell carcinoma (SCC) who fail to respond to chemoradiotherapy so that they can undergo post-treatment salvage surgery while the disease is still operable. This study aimed to determine the diagnostic performance of dynamic contrast enhanced (DCE)-MRI using a pharmacokinetic model for pre-treatment predictive imaging, as well as post-treatment diagnosis, of residual SCC at primary and nodal sites in the head and neck. MATERIAL AND METHODS:Forty-nine patients with 83 SCC sites (primary and/or nodal) underwent pre-treatment DCE-MRI, and 43 patients underwent post-treatment DCE-MRI, of which 33 SCC sites had a residual mass amenable to analysis. Pre-treatment, post-treatment and % change in the mean Ktrans, kep, ve and AUGC were obtained from SCC sites. Logistic regression was used to correlate DCE parameters at each SCC site with treatment response at the same site, based on clinical outcome at that site at a minimum of two years. RESULTS:None of the pre-treatment DCE-MRI parameters showed significant correlations with SCC site failure (SF) (29/83 sites) or site control (SC) (54/83 sites). Post-treatment residual masses with SF (14/33) had significantly higher kep (p = 0.05), higher AUGC (p = 0.02), and lower % reduction in AUGC (p = 0.02), than residual masses with SC (19/33), with the % change in AUGC remaining significant on multivariate analysis. CONCLUSION:Pre-treatment DCE-MRI did not predict which SCC sites would fail treatment, but post-treatment DCE-MRI showed potential for identifying residual masses that had failed treatment.
first_indexed 2024-12-22T16:36:19Z
format Article
id doaj.art-1fc3bb5b62a8456eafce50643aa00893
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-22T16:36:19Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-1fc3bb5b62a8456eafce50643aa008932022-12-21T18:19:57ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011012e014477010.1371/journal.pone.0144770DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck.Ann D KingSteven Kwok Keung ChowKwok-Hung YuFrankie Kwok Fai MoDavid K W YeungJing YuanBenjamin King Hong LawKunwar S BhatiaAlexander C VlantisAnil T AhujaBACKGROUND AND PURPOSE:It is important to identify patients with head and neck squamous cell carcinoma (SCC) who fail to respond to chemoradiotherapy so that they can undergo post-treatment salvage surgery while the disease is still operable. This study aimed to determine the diagnostic performance of dynamic contrast enhanced (DCE)-MRI using a pharmacokinetic model for pre-treatment predictive imaging, as well as post-treatment diagnosis, of residual SCC at primary and nodal sites in the head and neck. MATERIAL AND METHODS:Forty-nine patients with 83 SCC sites (primary and/or nodal) underwent pre-treatment DCE-MRI, and 43 patients underwent post-treatment DCE-MRI, of which 33 SCC sites had a residual mass amenable to analysis. Pre-treatment, post-treatment and % change in the mean Ktrans, kep, ve and AUGC were obtained from SCC sites. Logistic regression was used to correlate DCE parameters at each SCC site with treatment response at the same site, based on clinical outcome at that site at a minimum of two years. RESULTS:None of the pre-treatment DCE-MRI parameters showed significant correlations with SCC site failure (SF) (29/83 sites) or site control (SC) (54/83 sites). Post-treatment residual masses with SF (14/33) had significantly higher kep (p = 0.05), higher AUGC (p = 0.02), and lower % reduction in AUGC (p = 0.02), than residual masses with SC (19/33), with the % change in AUGC remaining significant on multivariate analysis. CONCLUSION:Pre-treatment DCE-MRI did not predict which SCC sites would fail treatment, but post-treatment DCE-MRI showed potential for identifying residual masses that had failed treatment.http://europepmc.org/articles/PMC4684338?pdf=render
spellingShingle Ann D King
Steven Kwok Keung Chow
Kwok-Hung Yu
Frankie Kwok Fai Mo
David K W Yeung
Jing Yuan
Benjamin King Hong Law
Kunwar S Bhatia
Alexander C Vlantis
Anil T Ahuja
DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck.
PLoS ONE
title DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck.
title_full DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck.
title_fullStr DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck.
title_full_unstemmed DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck.
title_short DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck.
title_sort dce mri for pre treatment prediction and post treatment assessment of treatment response in sites of squamous cell carcinoma in the head and neck
url http://europepmc.org/articles/PMC4684338?pdf=render
work_keys_str_mv AT anndking dcemriforpretreatmentpredictionandposttreatmentassessmentoftreatmentresponseinsitesofsquamouscellcarcinomaintheheadandneck
AT stevenkwokkeungchow dcemriforpretreatmentpredictionandposttreatmentassessmentoftreatmentresponseinsitesofsquamouscellcarcinomaintheheadandneck
AT kwokhungyu dcemriforpretreatmentpredictionandposttreatmentassessmentoftreatmentresponseinsitesofsquamouscellcarcinomaintheheadandneck
AT frankiekwokfaimo dcemriforpretreatmentpredictionandposttreatmentassessmentoftreatmentresponseinsitesofsquamouscellcarcinomaintheheadandneck
AT davidkwyeung dcemriforpretreatmentpredictionandposttreatmentassessmentoftreatmentresponseinsitesofsquamouscellcarcinomaintheheadandneck
AT jingyuan dcemriforpretreatmentpredictionandposttreatmentassessmentoftreatmentresponseinsitesofsquamouscellcarcinomaintheheadandneck
AT benjaminkinghonglaw dcemriforpretreatmentpredictionandposttreatmentassessmentoftreatmentresponseinsitesofsquamouscellcarcinomaintheheadandneck
AT kunwarsbhatia dcemriforpretreatmentpredictionandposttreatmentassessmentoftreatmentresponseinsitesofsquamouscellcarcinomaintheheadandneck
AT alexandercvlantis dcemriforpretreatmentpredictionandposttreatmentassessmentoftreatmentresponseinsitesofsquamouscellcarcinomaintheheadandneck
AT aniltahuja dcemriforpretreatmentpredictionandposttreatmentassessmentoftreatmentresponseinsitesofsquamouscellcarcinomaintheheadandneck